药品详细
Pentolinium(安血定)
化学结构式图
中文名
安血定
英文名
Pentolinium
分子式
C15H32N2
化学名
1-methyl-1-[5-(1-methylpyrrolidin-1-ium-1-yl)pentyl]pyrrolidin-1-ium
分子量
Average: 240.428
Monoisotopic: 240.256549034
Monoisotopic: 240.256549034
CAS号
52-62-0
ATC分类
药物类型
small molecule
阶段
approved
商品名
同义名
基本介绍
A nicotinic antagonist that has been used as a ganglionic blocking agent in hypertension. [PubChem]
生产厂家
- Wyeth ayerst laboratories
封装厂家
参考
Synthesis Reference | Not Available |
General Reference | Not Available |
剂型
规格
化合物类型
Type | small molecule |
Classes |
|
Substructures |
|
适应症
药理
Indication | Used to produce controlled hypotension during surgical procedures and in hypertensive crises. |
Pharmacodynamics | Pentolinium acts as a ganglionic blocking agent. Pentolinium inhibits release of adrenaline and noradrenaline from adrenergic nerves. It is used as an antihypertensive, and can be administered orally, intramuscularly, and subcutaneously. |
Mechanism of action | Pentolinium binds to the nicotinic (ganglion) acetylcholine receptor. This receptor/channel is permeable to a range of divalent cations including calcium, the influx of which may activate a potassium current which hyperpolarizes the cell membrane. Blockage of the receptor leads to smooth muscle relaxation and vasodilaton. |
Absorption | Not Available |
Volume of distribution | Not Available |
Protein binding | Not Available |
Metabolism |
Not Available
|
Route of elimination | Not Available |
Half life | Not Available |
Clearance | Not Available |
Toxicity | Oral, mouse: LD50 = 512 mg/kg; Oral, rat: LD50 = 890 mg/kg. |
Affected organisms |
|
Pathways | Not Available |
理化性质
Properties | |||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
State | solid | ||||||||||||||||||||||||||||||||||||
Experimental Properties |
|
||||||||||||||||||||||||||||||||||||
Predicted Properties |
|
药物相互作用
食物相互作用
Not Available